Monday, 28 September 2026Updated 17m ago
← Top stories
▲ Bullish for Zydus Lifesciences

Zydus Lifesciences’ New Jersey office clears USFDA inspection with no observations

2 sources · first seen 13:22 26 Sept · updated 23:11 26 Sept

The brief

Written from 2 reports · check the source before you trade
  • USFDA inspection concluded with nil observations
  • Inspection covered pharmacovigilance and post-marketing surveillance from September 22 to 25
  • A clean USFDA inspection supports confidence in Zydus Lifesciences’ US operations

Tags on this story

Pick a tag to see all its stories
Zydus Lifesciences₹1,203.90 · 2 todayUSFDA2 todayPharma and healthcare19 today

Linked by the tag Zydus Lifesciences

5 stories this week
  1. 25 SeptIndian stock market slides, but 28 Nifty 500 stocks hit fresh 1-year highs this week; MCX, PVR Inox among themMarket move · 1 source · Nifty 50 fell 0.88% over the week, its biggest decline since 2020
All Zydus Lifesciences stories →

Read the reports

2 reports · earliest 13:22
CNBC-TV18Zydus Lifesciences says USFDA inspection at New Jersey office concludes with nil observations13:22Business LineZydus Lifesciences’ New Jersey facility clears USFDA inspection with nil observations23:11